Jixin Li

ORCID: 0000-0002-5581-0065 · 9 papers in corpus · active 2022-2025

Study types

  • article 5
  • other 2
  • preprint 2

Condition tags

  • endometriosis 9
  • mesh:D004715 5
  • infertility 2
  • dyspareunia 1
other 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1748838

[This corrects the article DOI: 10.3389/fimmu.2023.1115504.].

other 2025
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2025.1672521

BACKGROUND: Endometriosis is a common benign gynecologic disease in women of reproductive age, and its manifestations remarkably decrease quality of life. Lactate, as a metabolite, exerts prominent effects across a wide range of biological …

preprint 2024
·doi:10.21203/rs.3.rs-4509482/v1

Abstract Background: N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to…

preprint 2023
·doi:10.21203/rs.3.rs-3003927/v1

Abstract Background N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to …

article 2023
Journal of immunology research ·doi:10.1155/2023/2975581

Background. Endometriosis is an inflammatory gynecological disease leading to deep pelvic pain, dyspareunia, and infertility. The pathophysiology of endometriosis is complex and depends on a variety of biological processes and pathways. The…

article 2023
Journal of translational medicine ·doi:10.1186/s12967-023-04209-0

BACKGROUND: Endometriosis (EMs), the ectopic planting of functional endometrium outside of the uterus, is a leading cause of infertility and pelvic pain. As a fundamental mRNA modification, N6-methyladenosine (m6A) participates in various p…

article 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1115504

Background: Endometriosis (EM) is a benign, multifactorial, immune-mediated inflammatory disease that is characterized by persistent activation of the NF-κB signaling pathway and some features of malignancies, such as proliferation and lymp…

article 2022
DNA and cell biology ·doi:10.1089/dna.2021.1017

), a potential target of miR-21-5p, is downregulated in endometriotic specimens. However, the function of CPEB3 in endometriosis is elusive. In this study, in cultured primary human endometrial stromal cells (ESCs), the overexpression and i…

article 2022
Epigenomics ·doi:10.2217/epi-2022-0249

Aim: To identify epigenetic alterations of differentially expressed genes and screen out targeted therapeutic drugs in endometriosis. Methods: Based on the Gene Expression Omnibus database and a series of biological information analysis too…